328 related articles for article (PubMed ID: 21812107)
21. Schisanhenol Attenuates OxLDL-Induced Endothelial Dysfunction via an AMPK-Dependent Mechanism.
Chiu TH; Ku CW; Ho TJ; Tsai KL; Hsu WC; Chen YA; Ou HC; Chen HI
Am J Chin Med; 2023; 51(6):1459-1475. PubMed ID: 37518097
[TBL] [Abstract][Full Text] [Related]
22. A protective role of ciglitazone in ox-LDL-induced rat microvascular endothelial cells via modulating PPARγ-dependent AMPK/eNOS pathway.
Xu L; Wang S; Li B; Sun A; Zou Y; Ge J
J Cell Mol Med; 2015 Jan; 19(1):92-102. PubMed ID: 25388834
[TBL] [Abstract][Full Text] [Related]
23. Phosphocreatine protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway.
Ahsan A; Han G; Pan J; Liu S; Padhiar AA; Chu P; Sun Z; Zhang Z; Sun B; Wu J; Irshad A; Lin Y; Peng J; Tang Z
Apoptosis; 2015 Dec; 20(12):1563-76. PubMed ID: 26404526
[TBL] [Abstract][Full Text] [Related]
24. Ezetimibe Protects Endothelial Cells against Oxidative Stress through Akt/GSK-3β Pathway.
Qin J; Wang LL; Liu ZY; Zou YL; Fei YJ; Liu ZX
Curr Med Sci; 2018 Jun; 38(3):398-404. PubMed ID: 30074204
[TBL] [Abstract][Full Text] [Related]
25. Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway.
Dandapat A; Hu C; Sun L; Mehta JL
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2435-42. PubMed ID: 17717293
[TBL] [Abstract][Full Text] [Related]
26. Protective effects of let-7a and let-7b on oxidized low-density lipoprotein induced endothelial cell injuries.
Bao MH; Zhang YW; Lou XY; Cheng Y; Zhou HH
PLoS One; 2014; 9(9):e106540. PubMed ID: 25247304
[TBL] [Abstract][Full Text] [Related]
27. Paeonol suppresses oxidized low-density lipoprotein induced endothelial cell apoptosis via activation of LOX-1/p38MAPK/NF-κB pathway.
Bao MH; Zhang YW; Zhou HH
J Ethnopharmacol; 2013 Mar; 146(2):543-51. PubMed ID: 23357312
[TBL] [Abstract][Full Text] [Related]
28. Metformin regulates oxLDL-facilitated endothelial dysfunction by modulation of SIRT1 through repressing LOX-1-modulated oxidative signaling.
Hung CH; Chan SH; Chu PM; Lin HC; Tsai KL
Oncotarget; 2016 Mar; 7(10):10773-87. PubMed ID: 26885898
[TBL] [Abstract][Full Text] [Related]
29. LOX-1 and ROS, inseparable factors in the process of endothelial damage.
Lubrano V; Balzan S
Free Radic Res; 2014 Aug; 48(8):841-8. PubMed ID: 24886290
[TBL] [Abstract][Full Text] [Related]
30. Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis.
Lu J; Yang JH; Burns AR; Chen HH; Tang D; Walterscheid JP; Suzuki S; Yang CY; Sawamura T; Chen CH
Circ Res; 2009 Mar; 104(5):619-27. PubMed ID: 19150883
[TBL] [Abstract][Full Text] [Related]
31. AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A/NF-κB/LOX-1 pathway.
Chen B; Li J; Zhu H
Vascul Pharmacol; 2016 Oct; 85():1-10. PubMed ID: 26297684
[TBL] [Abstract][Full Text] [Related]
32. Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1.
Cimmino G; Cirillo P; Conte S; Pellegrino G; Barra G; Maresca L; Morello A; Calì G; Loffredo F; De Palma R; Arena G; Sawamura T; Ambrosio G; Golino P
Cardiovasc Res; 2020 May; 116(6):1125-1135. PubMed ID: 31504248
[TBL] [Abstract][Full Text] [Related]
33. Schisanhenol ameliorates oxLDL-caused endothelial dysfunction by inhibiting LOX-1 signaling.
Chiu TH; Ku CW; Ho TJ; Tsai KL; Yang YD; Ou HC; Chen HI
Environ Toxicol; 2023 Jul; 38(7):1589-1596. PubMed ID: 36999521
[TBL] [Abstract][Full Text] [Related]
34. Luteolin protects HUVECs from TNF-α-induced oxidative stress and inflammation via its effects on the Nox4/ROS-NF-κB and MAPK pathways.
Xia F; Wang C; Jin Y; Liu Q; Meng Q; Liu K; Sun H
J Atheroscler Thromb; 2014; 21(8):768-83. PubMed ID: 24621786
[TBL] [Abstract][Full Text] [Related]
35. Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats.
Mita S; Kobayashi N; Yoshida K; Nakano S; Matsuoka H
J Hypertens; 2005 Jan; 23(1):87-96. PubMed ID: 15643129
[TBL] [Abstract][Full Text] [Related]
36. Thioredoxin attenuates oxidized low-density lipoprotein induced oxidative stress in human umbilical vein endothelial cells by reducing NADPH oxidase activity.
Chen B; Meng L; Shen T; Gong H; Qi R; Zhao Y; Sun J; Bao L; Zhao G
Biochem Biophys Res Commun; 2017 Sep; 490(4):1326-1333. PubMed ID: 28688762
[TBL] [Abstract][Full Text] [Related]
37. Salidroside attenuates oxidized low‑density lipoprotein‑induced endothelial cell injury via promotion of the AMPK/SIRT1 pathway.
Zhao D; Sun X; Lv S; Sun M; Guo H; Zhai Y; Wang Z; Dai P; Zheng L; Ye M; Wang X
Int J Mol Med; 2019 Jun; 43(6):2279-2290. PubMed ID: 30942428
[TBL] [Abstract][Full Text] [Related]
38. LOX-1 receptor blockade abrogates oxLDL-induced oxidative DNA damage and prevents activation of the transcriptional repressor Oct-1 in human coronary arterial endothelium.
Thum T; Borlak J
J Biol Chem; 2008 Jul; 283(28):19456-64. PubMed ID: 18390905
[TBL] [Abstract][Full Text] [Related]
39. OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators.
Valente AJ; Irimpen AM; Siebenlist U; Chandrasekar B
Free Radic Biol Med; 2014 May; 70():117-28. PubMed ID: 24561578
[TBL] [Abstract][Full Text] [Related]
40. AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes.
Wang S; Zhang M; Liang B; Xu J; Xie Z; Liu C; Viollet B; Yan D; Zou MH
Circ Res; 2010 Apr; 106(6):1117-28. PubMed ID: 20167927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
